"uuid:ID","instanceType","description","label","text","name","id"
"af1dc453-c558-458e-92ba-12b22fda714e","OBJECTIVE","Main objective","","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","OBJ1","Objective_1"
"c64657fa-e6e7-4d6e-a8d4-2120c157b549","OBJECTIVE","Safety","","To document the safety profile of the xanomeline TTS.","OBJ2","Objective_2"
"52589f6e-b7e2-420e-a139-aed8f8491c54","OBJECTIVE","Behaviour","","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","OBJ3","Objective_3"
